PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
94.45
+1.75 (1.89%)
Nov 21, 2024, 4:00 PM EST - Market closed
PROCEPT BioRobotics Revenue
PROCEPT BioRobotics had revenue of $58.37M in the quarter ending September 30, 2024, with 66.29% growth. This brings the company's revenue in the last twelve months to $199.84M, up 71.71% year-over-year. In the year 2023, PROCEPT BioRobotics had annual revenue of $136.19M with 81.55% growth.
Revenue (ttm)
$199.84M
Revenue Growth
+71.71%
P/S Ratio
24.25
Revenue / Employee
$319,238
Employees
626
Market Cap
5.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 136.19M | 61.18M | 81.55% |
Dec 31, 2022 | 75.01M | 40.54M | 117.60% |
Dec 31, 2021 | 34.47M | 26.76M | 346.72% |
Dec 31, 2020 | 7.72M | 1.55M | 25.09% |
Dec 31, 2019 | 6.17M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Select Medical Holdings | 6.97B |
Lantheus Holdings | 1.50B |
Stevanato Group | 1.22B |
Inspire Medical Systems | 755.59M |
ADMA Biologics | 382.81M |
Krystal Biotech | 241.52M |
Arcellx | 155.82M |
Avidity Biosciences | 10.12M |
PRCT News
- 22 days ago - PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock - GlobeNewsWire
- 24 days ago - PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock - GlobeNewsWire
- 24 days ago - Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential - Benzinga
- 24 days ago - PROCEPT BioRobotics Corporation (PRCT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance - GlobeNewsWire
- 6 weeks ago - PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024 - GlobeNewsWire
- 6 weeks ago - PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer - GlobeNewsWire
- 3 months ago - PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024 - GlobeNewsWire